47 Results for "

orally efficacious

" in MedChemExpress (MCE) Product Catalog:
Products (47)

47 Results for "orally efficacious" in MCE Product Catalog:

18
18 Publications Verification
Cat. No.: HY-15253
CAS No.: 393105-53-8
Purity:  99.03%
Synonyms: PAI-039; Tiplasinin
Target:  

PAI-1 Apoptosis

Research Areas:  

Metabolic Disease Cancer

Tiplaxtinin is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 μM .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-16911
CAS No.: 620175-39-5
Synonyms: API-1252; Debio 1452
Target:  

Bacterial Antibiotic

Research Areas:  

Infection

AFN-1252 is an orally active and selective inhibitor of FabI, an essential enzyme in fatty acid biosynthesis in Staphylococcus spp. AFN-1252 exhibits exquisite and highly selective activity against Staphylococcus spp. AFN-1252 exhibits typical MIC90 values of ⩽0.015 μg/ml against diverse clinical isolates of S. aureus. AFN-1252 is efficacious in a mouse model of septicemia providing 100% protection from an otherwise lethal peritoneal infection of S. aureus Smith .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-15200
CAS No.: 1188910-76-0
Purity:  99.78%
Synonyms: CEP-32496; RXDX-105
Target:  

Raf

Research Areas:  

Cancer

Agerafenib (CEP-32496; RXDX-105) is a highly potent and orally efficacious inhibitor of BRAF V600E with a Kd of 14 nM.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-N1428C
CAS No.: 3522-50-7
Synonyms: Iron(III) citrate; Zerenex
Ferric citrate (Iron(III) citrate), an orally active iron supplement, is an efficacious phosphate binder. Ferric citratee can be used for iron deficiency anemia and chronic kidney disease (CKD) research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10268
CAS No.: 330942-05-7
Purity:  98.02%
Synonyms: PRT054021
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Betrixaban (PRT054021) is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban shows antithrombotic effect .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10268A
CAS No.: 936539-80-9
Purity:  99.78%
Synonyms: PRT054021 maleate
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Betrixaban (PRT054021) maleate is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban maleate shows antithrombotic effect .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-153321
CAS No.: 2649400-34-8
Purity:  98.67%
Synonyms: NX-5948; BTK-IN-24
Target:  

PROTACs Btk

Research Areas:  

Inflammation/Immunology

Bexobrutideg (NX-5948) is an orally active chimeric targeting molecule (CTM) that induces specific BTK protein degradation by the cereblon E3 ligase (CRBN) complex without degradation of other cereblon neo-substrates. Bexobrutideg mediates potent anti-inflammatory activity via BTK degradation with resultant inhibition of B cell activation. Bexobrutideg exhibits potent tumor growth inhibition in TMD8 xenograft models that contain either wild-type BTK or BTKi-resistant mutations. Bexobrutideg is efficacious in a mouse collageninduced arthritis (CIA) model. Bexobrutideg can cross the blood brain barrier (BBB). Bexobrutideg is a PROTAC composed of the ligand for target protein, a linker, and a cereblon E3 ligase (CRBN) complex (Red: BTK ligand (HY-170324); Blue: CRBN ligand (HY-171893); Black: linker) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12445
CAS No.: 1421693-22-2
Purity:  99.18%
Synonyms: CDKI-73; LS-007
Target:  

CDK Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Asnuciclib (CDKI-73; LS-007) is an orally active and highly efficacious CDK9 inhibitor, with Ki values of 4 nM, 4 nM and 3 nM for CDK9, CDK1 and CDK2, respectively. Asnuciclib down-regulates the RNAPII phosphorylation. Asnuciclib is also a novel pharmacological inhibitor of Rab11 cargo delivery and innate immune secretion .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-111745
CAS No.: 1797432-62-2
Purity:  99.35%
Target:  

JAK

Research Areas:  

Inflammation/Immunology

Tyk2-IN-5 (compound 6) is a potent, selective and orally active tyrosine kinase 2 (Tyk2) inhibitor that acts on the JH2 structural domain. Tyk2-IN-5 shows a Ki value of 0.086 nM for Tyk2 JH2 and an IC50 value of 25 nM for IFNα. Tyk2-IN-5 efficiently inhibits the production of IFNγ in a pharmacodynamic rat model and is fully efficacious in a rat model of arthritis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10596
CAS No.: 893397-44-9
Purity:  98.51%
Target:  

Integrin

Research Areas:  

Inflammation/Immunology

BMS-688521 is a highly potent, orally active inhibitor of the LFA-1/ICAM interaction, with an IC50 of 2.5 nM in the adhesion assay and an IC50 of 60 nM in the MLR assay. BMS-688521 is efficacious in a mouse allergic eosinophilic lung inflammation model .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14390
CAS No.: 925676-48-8
Purity:  99.92%
Target:  

Adenosine Receptor

Research Areas:  

Inflammation/Immunology

LAS101057 is a potent, selective, and orally efficacious A2B receptor antagonist.
loading...
    loading...
Cat. No.: HY-112542
CAS No.: 102130-84-7
Purity:  99.79%
Synonyms: CL-287088; LL-F28249 α
Nemadectin (CL-287088), an orally active broad-spectrum endectocide, is highly efficacious against natural infections of all the major canine gastrointestinal helminthes. Anthelmintic activity .
loading...
    loading...
Cat. No.: HY-141692
CAS No.: 2446803-65-0
Purity:  99.00%
Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology Cancer

IL-17 modulator 4 is a proagent of IL-17 modulator 1 (HY-141535). IL-17 modulator 1 is an orally active, highly efficacious IL-17 modulator. IL-17 modulator 4 is promising for the research of IL-17A mediated diseases, including inflammation, autoimmune diseases, infectious diseases, cancer, and precancerous syndrome .
loading...
    loading...
Cat. No.: HY-47030
CAS No.: 2338-05-8
Ferric citrate hydrate, an orally active iron supplement, is an efficacious phosphate binder. Ferric citrate hydrate can be used for iron deficiency anemia and chronic kidney disease (CKD) research .
loading...
    loading...
Cat. No.: HY-130253
CAS No.: 2454244-02-9
Purity:  99.30%
Target:  

IRAK

Research Areas:  

Cancer

IRAK4-IN-6 is an orally efficacious and selective IRAK4 inhibitor with an IC50 of 4 nM, and targetes MyD88 L265P mutant diffuse large B cell lymphoma .
loading...
    loading...
Cat. No.: HY-15199
CAS No.: 1227678-26-3
Synonyms: CEP-32496 hydrochloride; RXDX-105 hydrochloride
Target:  

Raf

Research Areas:  

Cancer

Agerafenib hydrochloride is a highly potent and orally efficacious inhibitor of BRAF V600E with a Kd of 14 nM.
loading...
    loading...
Cat. No.: HY-10268S
CAS No.: 2098655-51-5
Purity:  99.02%
Synonyms: PRT054021-d6
Betrixaban-d6 is a deuterium labeled Betrixaban. Betrixaban is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor .
loading...
    loading...
Cat. No.: HY-10268B
CAS No.: 2099719-47-6
Synonyms: PRT054021 hydrochloride
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Betrixaban (PRT054021) hydrochloride is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban hydrochloride shows antithrombotic effect .
loading...
    loading...
Cat. No.: HY-102036
CAS No.: 1346669-54-2
Target:  

Btk

Research Areas:  

Inflammation/Immunology

G-744 is a highly potent, selective and orally active Btk inhibitor with an IC50 of 2 nM. G-744 is metabolically stable, well tolerated and efficacious to treat arthritis .
loading...
    loading...
Cat. No.: HY-10268R
CAS No.: 330942-05-7
Synonyms: PRT054021 (Standard)
Research Areas:  

Cardiovascular Disease

Betrixaban (Standard) is the analytical standard of Betrixaban. This product is intended for research and analytical applications. Betrixaban (PRT054021) is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban shows antithrombotic effect .
loading...
    loading...